21 November 2022
More than 80% of medicines from the Vital and Essential Drugs list ones are produced domestically, and more than 30% of medical devices are Russian-made, said Yevgeny Kamkin, Deputy Minister of Health of the Russian Federation.
“Currently, more than 80% of medicines from the national reimbursement list are produced in Russia, and 31% of medical devices today are Russian-made,” Kamkin said at a videoconference with Amin Al Ameeri, Assistant Undersecretary in UAE Ministry of Health.
According to him, the market of medical devices in Russia demonstrates noticeable growth — 1.8 times over the past four years.
Kamkin also added that the Russian healthcare system currently employs more than 2 million doctors and paramedical personnel, and there are over 259,000 healthcare facilities in the country.
The Deputy Minister noted that last year more than 3 million foreign citizens used medical services in Russia, with the most popular sectors of medical care being diagnostic examinations, oncological care, surgery, traumatology, ophthalmology, and pediatrics.
Kamkin noted that the Russian side is interested in cooperation with the UAE, exchange of experience, and joint work on a number of topical issues on the international health agenda. These include research and development in medicine, digital healthcare, vaccines development, production and supply, the fight against non-communicable diseases, and the provision of medicines to the population.
PrintOctober 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
The Ministry of Health approved a new indication for a non-small cell lung cancer drug
07 November 2024
Special rules for medicines and medical devices may extend to 2028
07 November 2024
Murashko discussed the progress of Russian innovative drugs
06 November 2024
The volume of production of dietary supplements increased by 27% in 2024 in Moscow
06 November 2024